175 related articles for article (PubMed ID: 23031302)
41. Infliximab for the treatment of psoriasis: clinical experience at the State University of New York at Buffalo.
Kalb RE; Gurske J
J Am Acad Dermatol; 2005 Oct; 53(4):616-22. PubMed ID: 16198781
[TBL] [Abstract][Full Text] [Related]
42. Alopecia areata during treatment with biologic agents.
Tosti A; Pazzaglia M; Starace M; Bellavista S; Vincenzi C; Tonelli G
Arch Dermatol; 2006 Dec; 142(12):1653-4. PubMed ID: 17179002
[No Abstract] [Full Text] [Related]
43. [Blasch-kolinear psoriasis revealed by infliximab therapy].
Sfia M; Roth-Mall B; Tortel MC; Guillaume JC; Cribier B
Ann Dermatol Venereol; 2009 Dec; 136(12):898-903. PubMed ID: 20004317
[TBL] [Abstract][Full Text] [Related]
44. Body weight increment in patients treated with infliximab for plaque psoriasis.
Florin V; Cottencin AC; Delaporte E; Staumont-Sallé D
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e186-90. PubMed ID: 22621415
[TBL] [Abstract][Full Text] [Related]
45. [Infliximab: patients selection].
Puig L
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():23-9. PubMed ID: 19080988
[TBL] [Abstract][Full Text] [Related]
46. Treatment of psoriasis: focus on clinic-based management with infliximab.
de Eusebio E; Armario-Hita JC; de Miquel VA
Am J Clin Dermatol; 2014 Feb; 15 Suppl 1():S5-16. PubMed ID: 24777571
[TBL] [Abstract][Full Text] [Related]
47. [Efficacy of infliximab in patients with moderate and severe psoriasis treated with infliximab (Remicade)].
Valdés A Mdel P; Schroeder H F; Roizen G V; Honeyman M J; Sánchez M L
Rev Med Chil; 2006 Mar; 134(3):326-31. PubMed ID: 16676105
[TBL] [Abstract][Full Text] [Related]
48. Infliximab associated new-onset psoriasis.
Adams DR; Buckel T; Sceppa JA
J Drugs Dermatol; 2006 Feb; 5(2):178-9. PubMed ID: 16485887
[TBL] [Abstract][Full Text] [Related]
49. [Reactions to infliximab infusions in dermatologic patients: consensus statement and treatment protocol. Working Group of the Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología ].
Puig Sanz L; Sáez E; Lozano MJ; Bordas X; Carrascosa JM; Gallardo F; Luelmo J; Sánchez-Regaña M; Alsina M; García-Patos V;
Actas Dermosifiliogr; 2009 Mar; 100(2):103-12. PubMed ID: 19445874
[TBL] [Abstract][Full Text] [Related]
50. Counter-regulatory balance: atopic dermatitis in patients undergoing infliximab infusion therapy.
Chan JL; Davis-Reed L; Kimball AB
J Drugs Dermatol; 2004; 3(3):315-8. PubMed ID: 15176169
[TBL] [Abstract][Full Text] [Related]
51. Psoriasis and its treatment with infliximab-mediated tumor necrosis factor alpha blockade.
Winterfield L; Menter A
Dermatol Clin; 2004 Oct; 22(4):437-47, ix. PubMed ID: 15450339
[TBL] [Abstract][Full Text] [Related]
52. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors: An update on infliximab.
Brunasso AM; Massone C
Acta Derm Venereol; 2011 Jan; 91(1):70-1. PubMed ID: 21103830
[No Abstract] [Full Text] [Related]
53. [Splenic tuberculosis during psoriasis treatment with infliximab].
Fortaleza GT; Brito Mde F; Santos JB; Figueiredo AR; Gomes P
An Bras Dermatol; 2009; 84(4):420-4. PubMed ID: 19851677
[TBL] [Abstract][Full Text] [Related]
54. Different response rates between palmoplantar involvement and diffuse plaque psoriasis in patients treated with infliximab.
Brunasso AM; Puntoni M; Delfino C; Massone C
Eur J Dermatol; 2012; 22(1):133-5. PubMed ID: 22134100
[No Abstract] [Full Text] [Related]
55. Induction of lesional and circulating leukocyte apoptosis by infliximab in a patient with moderate to severe psoriasis.
Malaviya R; Sun Y; Tan JK; Magliocco M; Gottlieb AB
J Drugs Dermatol; 2006 Oct; 5(9):890-3. PubMed ID: 17039656
[TBL] [Abstract][Full Text] [Related]
56. Combination treatment with a tumour necrosis factor antagonist and an oral retinoid: efficacy in severe acral psoriasis?
Ingram JR; Anstey AV; Piguet V
Br J Dermatol; 2012 Oct; 167(4):949-51. PubMed ID: 22486276
[No Abstract] [Full Text] [Related]
57. [Legionella pneumonia in patients treated with infliximab].
Vinter H; Nielsen HI
Ugeskr Laeger; 2009 Jan; 171(4):247. PubMed ID: 19174042
[TBL] [Abstract][Full Text] [Related]
58. Infliximab in the treatment of psoriasis in patients previously treated with etanercept.
Haitz KA; Kalb RE
J Am Acad Dermatol; 2007 Jul; 57(1):120-5. PubMed ID: 17482715
[TBL] [Abstract][Full Text] [Related]
59. Use of biologic agents in pediatric psoriasis.
Marji JS; Marcus R; Moennich J; Mackay-Wiggan J
J Drugs Dermatol; 2010 Aug; 9(8):975-86. PubMed ID: 20684148
[TBL] [Abstract][Full Text] [Related]
60. Infliximab-induced pityriasis lichenoides chronica in a patient with psoriasis.
Newell EL; Jain S; Stephens C; Martland G
J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):230-1. PubMed ID: 18680531
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
